Patents by Inventor Susan E. Carlson

Susan E. Carlson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nutritional supplement
    Publication number: 20040265462
    Abstract: A nutritional supplement comprising an infant milk formula having long chain poly unsaturated fatty acids, sialic acids, and cholesterol.
    Type: Application
    Filed: June 23, 2004
    Publication date: December 30, 2004
    Applicant: University of Kansas Medical Center
    Inventor: Susan E. Carlson
  • Methods for reducing the incidence of necrotizing enterocolitis
    Patent number: 6306908
    Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), e.g., arachidonic acid (AA), and docosahexaenoic acid (DHA), essentially free of cholesterol, are described for use in methods for reducing the incidence of necrotizing enterocolitis. Compositions from egg yolk lipids are preferred as they contain &ohgr;-6 and &ohgr;-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergetic effect.
    Type: Grant
    Filed: May 12, 2000
    Date of Patent: October 23, 2001
    Assignee: Abbott Laboratories
    Inventors: Susan E. Carlson, Debra L. Ponder, Michael B. Montalto, Margaret H. Dohnalek, John D. Benson, David A. Borror, David V. Diodato
  • Methods for reducing the incidence of necrotizing enterocolitis
    Patent number: 6080787
    Abstract: Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs), as arachidonic acid (AA) and docosahexaenoic acid (DHA) that are essentially free of cholesterol, are described. More particularly, the invention relates to methods for reducing the incidence of necrotizing enterocolitis by administering compositions which provide .omega.-6 and .omega.-3 long chain PUFAs, phospholipids and/or choline. Compositions from egg yolk lipids are presently preferred as they contain .omega.-6 and .omega.-3 long chain PUFAs and are predominantly in a phosphtidylcholine form. This is believed to provide a synergistic effect.
    Type: Grant
    Filed: October 3, 1997
    Date of Patent: June 27, 2000
    Assignee: Abbott Laboratories
    Inventors: Susan E. Carlson, Debra L. Ponder, Michael B. Montalto, Margaret H. Dohnalek, John D. Benson, David A. Borror, David V. Diodato